Follow-up, Malignant Female Reproductive System Neoplasm, Psychosocial Circumstances, Supportive Care, Survivorship
Conditions
Keywords
Self-management intervention, Psychosocial care, Autonomy-supportive, Gynaecological cancer survivors, Guided self-Determination
Brief summary
Women treated for gynaecological cancer perceive many difficulties in life on the personal, social, and physical levels. Today they are offered a 3 to 5 year follow-up programme at the hospital where the main purpose is to improve survival. However, the women are very nervous before follow-up visits and although they feel safe about them, they express that their needs of psychosocial care and self-management support are not fulfilled. The proposed study will test a person-centred intervention tailored the women's needs in a randomised controlled trial. The intervention will be based on the method Guided Self Determination (GSD), which has proved able to realize empowerment in practice in relationships between patients and healthcare professionals. GSD involves systematic use of condition-adjusted worksheets ('reflection sheets'), and advanced professional communication. Using reflection sheets filled out by each woman as the starting point for communication, problem solving will be tailored her personal needs. We expect that the intervention has the potential to support the women in better managing specific complications and difficulties related to concerns about recovery, body perception, fertility and establishment of intimate relations with their partner, all aspects important for the women's quality of life in the follow-up period after cancer diagnosis and treatment. The study will be the first to test GSD in cancer patients.
Interventions
BEHAVIORALAutonomy supportive counselling
Sponsors
Rigshospitalet, Denmark
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Women only surgically treated for cervix, ovarian (including borderline tumors), endometrial or vulva cancer, who attend follow up at the Gynaecological Department at The University Hospital Rigshospitalet in Copenhagen. * The women should read, write and understand the danish language.
Exclusion criteria
* Known recurrence. * Participation in the preliminary pilotstudy. * Health related problems both physical or psychological, that prevent participation. For example cognitive impairment, or patients with psychiatric diseases that is estimated to require nurses with competences within the psychiatric speciality.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Outcome: Quality of life measured by the scale Quality of life- Cancer Survivors (QOL-CS) | 9 months after randomisation | +/- one week for practical reasons |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-esteem measured by Rosenbergs Self Esteem Scale | 3 and 9 months after randomisation | +/- one week for practical reasons |
| Quality of Life measured by the scale Quality of Life Cancer Survivors- (QOL-CS) | 3 months after randomisation | +/- one week for practical reasons |
| Changes in Quality of life in the two groups | 9 months | Quality of life at 9 months minus the quality of life at the time of randomisation. |
| Positive and negative impact of cancer measured by Impact of Cancer version 2 (IOCv2) | 3 and 9 months after randomisation | +/- one week for practical reasons |
| Autonomy-supportive relationship between patient and health care professionals measured by Health Care Climate Questionnaire (HCCQ) | 3 and 9 months from randomisation | +/- one week for practical reasons |
| Distress measured by Distress Thermometer(DT). | 3 and 9 months from randomisation | Also used as screening instrument baseline. +/- one week for practical reasons. |
| Symptom monitoring and recognition | 3 and 9 months after randomisation (+/- one week for practical reasons) | Womens ability to know what symptoms to monitor and react to in case of recurrence |
| Anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS) | 3 and 9 months from randomisation | Also used as screening instrument baseline. +/- one week for practical reasons |
Countries
Denmark
Outcome results
None listed